H, B., S, S., E, L., A, L., Q, L., B, G., . . . S, D. (2026). Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model. Blood advances, 10(2), 289. https://doi.org/10.1182/bloodadvances.2025017321
Chicago Style (17th ed.) CitationH, Butt, et al. "Comparative Analysis of CRISPR-Cas9, Lentiviral Transduction, and Base Editing for Sickle Cell Disease in a Murine Model." Blood Advances 10, no. 2 (2026): 289. https://doi.org/10.1182/bloodadvances.2025017321.
MLA (9th ed.) CitationH, Butt, et al. "Comparative Analysis of CRISPR-Cas9, Lentiviral Transduction, and Base Editing for Sickle Cell Disease in a Murine Model." Blood Advances, vol. 10, no. 2, 2026, p. 289, https://doi.org/10.1182/bloodadvances.2025017321.